This inventor holds 1 USPTO granted patent. Top assignees: Korea Institute of Science and Technology, Scigenic Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010
Title: Hee-Sul Lee: Innovator in Neurodegenerative Disease Treatment
Introduction
Hee-Sul Lee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of neurodegenerative disease treatment through her innovative research and patents. Her work focuses on enhancing learning and memory retention abilities while minimizing side effects.
Latest Patents
Hee-Sul Lee holds a patent for "Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease." This invention relates to cinnamic acid dimers that demonstrate excellent effects on enhancing learning and memory retention in vivo. Importantly, these compounds exhibit fewer side effects, showing no hormone properties even with long-term administration. This makes them suitable for treating neurodegenerative diseases, including dementia.
Career Highlights
Throughout her career, Hee-Sul Lee has worked with esteemed organizations such as the Korea Institute of Science and Technology and Scigenic Co., Ltd. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to advancements in medical science.
Collaborations
Hee-Sul Lee has collaborated with notable colleagues, including Dong-Jin Kim and Kye-Jung Shin. These partnerships have fostered a collaborative environment that enhances research and development in her field.
Conclusion
Hee-Sul Lee's contributions to the treatment of neurodegenerative diseases through her innovative patent highlight her role as a leading inventor in this critical area of research. Her work continues to pave the way for advancements in medical treatments that improve the quality of life for individuals affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile